BUY Dr. Reddy's Laboratories — Sumeet Bagadia, 22 Sept 2026

bySumeet Bagadia, Choice BrokingHorizon: NA (inferred Intraday)22 Sept 2026, 10:29 am ISTvia Zee Business (Live)

Entry₹1,215.7Inferred

Target₹1,245

Stop loss₹1,190-2.11% risk

At expiry₹1,209.522 Sept 2026, 3:05 pm

Expired-0.51%

Follow Sumeet Bagadia for new calls(11% target hit, 74 closed calls)Get alerts Watch DRREDDY for new buy/sell callsGet alerts See 1 active Intraday pick this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Sept, 10:34 pm IST

3 supporting0 opposing

Supports the BUY call (3)

2 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·21 Sept · yesterday

Dr. Reddy's Laboratories has entered into an exclusive distribution and marketing agreement with Takeda Biopharmaceuticals India for Qdenga®, a dengue vaccine, in the private market in India. The agre

BSE · Company Update·18 Sept · 4d ago

JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?

NewsEt-Markets·16 Sept · 6d ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY Dr. Reddy's Laboratories Limited — Sumeet Bagadia, Choice Broking

AI Assessment